Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-06-17 Sale | 2021-03-05 8:54 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 4,000 | $72.15 | $288,610 | 4,009 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-10-03 Disposition | 2022-10-03 8:23 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 22,362 | $148.5 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:23 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 274,727 | $0 | 0 (Direct) | View |
| 2022-01-07 Option Award | 2022-01-07 9:18 pm | N/A 2032-01-07 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 34,500 | $0 | 64,135 (Direct) | View |
| 2022-01-06 Exercise | 2022-01-07 9:18 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 3,750 | $0 | 64,135 (Direct) | View |
| 2022-01-06 Tax Withholding | 2022-01-07 9:18 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 1,800 | $123.86 | 64,135 (Direct) | View |
| 2021-11-23 Exercise | 2021-11-26 4:26 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 885 | $20.79 | 64,624 (Direct) | View |
| 2021-11-23 Exercise | 2021-11-26 4:26 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 10,000 | $37.54 | 64,624 (Direct) | View |
| 2021-11-23 Exercise | 2021-11-26 4:26 pm | N/A 2027-09-04 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 13,885 | $0 | 64,624 (Direct) | View |
| 2021-01-06 Option Award | 2021-01-08 8:48 pm | N/A 2031-01-06 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 45,000 | $0 | 66,262 (Direct) | View |
| 2021-01-06 Tax Withholding | 2021-01-08 8:48 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 1,747 | $83.38 | 66,262 (Direct) | View |
| 2021-01-06 Exercise | 2021-01-08 8:48 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 3,750 | $0 | 66,262 (Direct) | View |
| 2020-11-25 Tax Withholding | 2020-11-27 9:47 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 1,361 | $90.14 | 13,278 (Direct) | View |
| 2020-11-25 Exercise | 2020-11-27 9:47 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 3,000 | $0 | 13,278 (Direct) | View |
| 2019-12-18 Tax Withholding | 2019-12-20 9:42 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 1,361 | $52.13 | 14,639 (Direct) | View |
| 2019-12-18 Exercise | 2019-12-20 9:42 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 3,000 | $0 | 14,639 (Direct) | View |
| 2019-11-25 Option Award | 2019-11-27 9:30 pm | N/A 2029-11-24 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 37,000 | $0 | 37,000 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 5:36 pm | N/A 2029-03-22 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 6,000 | $0 | 6,000 (Direct) | View |